Samjin’s anti-dementia drug targeting sales of 10 billion won this year
Published: 2013-06-21 06:58:00
Updated: 2013-06-21 06:58:00
Samjin Pharmaceutical said Thursday that the sales of its anti-dementia drug Neutoin (donepezil) will reach 10 billion won this year on growing demand due to the growing number of dementia patients triggered by fueled by the rapid aging of the country's population.
Neutoin, which is already on...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
